<DOC>
	<DOCNO>NCT01877538</DOCNO>
	<brief_summary>AIM : To validate tracer [ 11C ] donepezil use parasympathetic nervous system . MATERIALS AND METHODS : The Investigators include 7 healthy male age 45-75 study . The participant receive careful medical examination , include neurological examination , part inclusion process . The subject also MRI scan brain . PET/CT scan [ 11C ] donepezil conduct . Six subject receive two PET/CT scan - upper abdominal region head region two evaluate dynamic binding characteristic tracer internal organ . Additionally , one single subject receive 5 consecutive whole body PET scan estimate radioactive dosimetry tracer . PERSPECTIVES : The study potentially result development PET ligand image parasympathetic nervous system . This application research Parkinson 's disease , diabetes , heart disease disorder , autonomic nervous system involve</brief_summary>
	<brief_title>Study Investigate Ability 11CDonepezil PET Image Parasympathetic Nervous System</brief_title>
	<detailed_description>Please see publish paper wherein detail list : In vivo image human acetylcholinesterase density peripheral organ use 11C-donepezil : dosimetry , biodistribution , kinetic analysis . Gjerl√∏ff T , Jakobsen S , Nahimi A , Munk OL , Bender D , Alstrup AK , Vase KH , Hansen SB , Brooks DJ , Borghammer P. J Nucl Med . 2014 Nov ; 55 ( 11 ) :1818-24 .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>male 4575 year dementia , psychiatric disease , serious medical illness include type previous cancer , drug know interaction autonomic nervous system</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>